» Articles » PMID: 29183925

Cohort Profile: the TrueNTH Global Registry - an International Registry to Monitor and Improve Localised Prostate Cancer Health Outcomes

Overview
Journal BMJ Open
Specialty General Medicine
Date 2017 Nov 30
PMID 29183925
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Globally, prostate cancer treatment and outcomes for men vary according to where they live, their race and the care they receive. The TrueNTH Global Registry project was established as an international registry monitoring care provided to men with localised prostate cancer (CaP).

Participants: Sites with existing CaP databases in Movember fundraising countries were invited to participate in the international registry. In total, 25 Local Data Centres (LDCs) representing 113 participating sites across 13 countries have nominated to contribute to the project. It will collect a dataset based on the International Consortium for Health Outcome Measures (ICHOM) standardised dataset for localised CaP.

Findings To Date: A governance strategy has been developed to oversee registry operation, including transmission of reversibly anonymised data. LDCs are represented on the Project Steering Committee, reporting to an Executive Committee. A Project Coordination Centre and Data Coordination Centre (DCC) have been established. A project was undertaken to compare existing datasets, understand capacity at project commencement (baseline) to collect the ICHOM dataset and assist in determining the final data dictionary. 21/25 LDCs provided data dictionaries for review. Some ICHOM data fields were well collected (diagnosis, treatment start dates) and others poorly collected (complications, comorbidities). 17/94 (18%) ICHOM data fields were relegated to non-mandatory fields due to poor capture by most existing registries. Participating sites will transmit data through a web interface biannually to the DCC.

Future Plans: Recruitment to the TrueNTH Global Registry-PCOR project will commence in late 2017 with sites progressively contributing reversibly anonymised data following ethical review in local regions. Researchers will have capacity to source deidentified data after the establishment phase. Quality indicators are to be established through a modified Delphi approach in later 2017, and it is anticipated that reports on performance against quality indicators will be provided to LDCs.

Citing Articles

Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile.

Gordon N, Dooley C, Murphy A, Farooq W, Sullivan F, McDermott R BMJ Open. 2024; 14(12):e090207.

PMID: 39622568 PMC: 11624731. DOI: 10.1136/bmjopen-2024-090207.


Transforming a Large-Scale Prostate Cancer Outcomes Dataset to the OMOP Common Data Model-Experiences from a Scientific Data Holder's Perspective.

Sibert N, Soff J, La Ferla S, Quaranta M, Kremer A, Kowalski C Cancers (Basel). 2024; 16(11).

PMID: 38893186 PMC: 11171220. DOI: 10.3390/cancers16112069.


Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement.

Duwe G, Boehm K, Becker G, Ruckes C, Sparwasser P, Haack M World J Urol. 2024; 42(1):236.

PMID: 38619659 DOI: 10.1007/s00345-024-04950-1.


Prediction models of incontinence and sexual function one year after radical prostatectomy based on data from 20 164 prostate cancer patients.

Sibert N, Kurth T, Breidenbach C, Wesselmann S, Feick G, Carl E PLoS One. 2023; 18(12):e0295179.

PMID: 38039308 PMC: 10691723. DOI: 10.1371/journal.pone.0295179.


Radiation therapy margin reduction for patients with localized prostate cancer: A prospective study of the dosimetric impact and quality of life.

Kumarasiri A, Chetty I, Devpura S, Pradhan D, Aref I, Elshaikh M J Appl Clin Med Phys. 2023; 25(3):e14198.

PMID: 37952248 PMC: 10930006. DOI: 10.1002/acm2.14198.


References
1.
Sampurno F, Earnest A, Kumari P, Millar J, Davis I, Murphy D . Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria. Med J Aust. 2016; 204(8):319. DOI: 10.5694/mja15.01041. View

2.
Malhotra K, Buraimoh O, Thornton J, Cullen N, Singh D, Goldberg A . Electronic capture of patient-reported and clinician-reported outcome measures in an elective orthopaedic setting: a retrospective cohort analysis. BMJ Open. 2016; 6(6):e011975. PMC: 4916591. DOI: 10.1136/bmjopen-2016-011975. View

3.
Morgans A, van Bommel A, Stowell C, Abrahm J, Basch E, Bekelman J . Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015; 68(5):891-8. DOI: 10.1016/j.eururo.2015.06.007. View

4.
Wei J, Dunn R, Litwin M, Sandler H, Sanda M . Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000; 56(6):899-905. DOI: 10.1016/s0090-4295(00)00858-x. View

5.
Bellgard M, MacGregor A, Janon F, Harvey A, OLeary P, Hunter A . A modular approach to disease registry design: successful adoption of an internet-based rare disease registry. Hum Mutat. 2012; 33(10):E2356-66. DOI: 10.1002/humu.22154. View